Spirocyclic Hybrids of Nortropane and 1,3-Oxazinan-2-one Fragments.

Autor: Mandzhulo, Alexandr, Vashchenko, Iryna, Lukin, Oleg, Shishkina, Svetlana, Dolgonos, Grygoriy, Gerasov, Andrii, Yepishev, Vitaliy, Samofalova, Dariia, Fetyukhin, Volodymyr, Shivanyuk, Alexander

Publikováno v: Synthesis; Sep2024, Vol. 56 Issue 17, p2709-2730, 22p

Modelling of an autonomous Nav1.5 channel system as a part of in silico pharmacology study.

Autor: Rayevsky, Alexey, Samofalova, Dariia O., Maximyuk, Oleksandr, Platonov, Maxim, Hurmach, Vasyl, Ryabukhin, Sergey, Volochnyuk, Dmitriy

Publikováno v: Journal of Molecular Modeling; Jun2021, Vol. 27 Issue 6, p1-9, 9p

Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer.

Autor: Recondo G; INSERM U981, Gustave Roussy Cancer Campus, Villejuif, France.; Université Paris-Saclay, Paris, France., Mezquita L; Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France., Facchinetti F; INSERM U981, Gustave Roussy Cancer Campus, Villejuif, France.; Université Paris-Saclay, Paris, France., Planchard D; Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France., Gazzah A; Drug Development Department (DITEP), Gustave Roussy Cancer Campus, Villejuif, France., Bigot L; INSERM U981, Gustave Roussy Cancer Campus, Villejuif, France.; Université Paris-Saclay, Paris, France., Rizvi AZ; INSERM U981, Gustave Roussy Cancer Campus, Villejuif, France.; Université Paris-Saclay, Paris, France., Frias RL; INSERM U981, Gustave Roussy Cancer Campus, Villejuif, France.; Université Paris-Saclay, Paris, France., Thiery JP; Yong Loo Lin School of Medicine, National University of Singapore, Republic of Singapore.; Institute of Biomedicine and Health, Chinese Academy of Science, Beijing, P.R. China.; CCBIO, Department of Clinical Medicine, Faculty of Medicine and Dentistry, The University of Bergen, Bergen, Norway.; Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, Hong Kong University, Hong Kong.; CNRS UMR 7057 Matter and Complex Systems, University Paris Denis Diderot, Paris, France., Scoazec JY; Université Paris-Saclay, Paris, France.; Experimental and Translational Pathology Platform (PETRA), Genomic Platform-Molecular Biopathology Unit (BMO) and Biological Resource Center, AMMICA, INSERM US23/CNRS UMS3655, Gustave Roussy Cancer Campus, Villejuif, France.; Department of Medical Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France., Sourisseau T; INSERM U981, Gustave Roussy Cancer Campus, Villejuif, France.; Université Paris-Saclay, Paris, France., Howarth K; Inivata, Granta Park, United Kingdom., Deas O; XenTech, Evry, France., Samofalova D; Life Chemicals Inc., Ontario, Canada.; Institute of Food Biotechnology and Genomics NAS of Ukraine, Kyiv, Ukraine., Galissant J; INSERM U981, Gustave Roussy Cancer Campus, Villejuif, France.; Université Paris-Saclay, Paris, France., Tesson P; INSERM U981, Gustave Roussy Cancer Campus, Villejuif, France.; Université Paris-Saclay, Paris, France., Braye F; INSERM U981, Gustave Roussy Cancer Campus, Villejuif, France.; Université Paris-Saclay, Paris, France., Naltet C; Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France., Lavaud P; Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France., Mahjoubi L; Drug Development Department (DITEP), Gustave Roussy Cancer Campus, Villejuif, France., Abou Lovergne A; Université Paris-Saclay, Paris, France.; Department of Clinical Research, Gustave Roussy Cancer Campus, Villejuif, France., Vassal G; Department of Clinical Research, Gustave Roussy Cancer Campus, Villejuif, France., Bahleda R; Drug Development Department (DITEP), Gustave Roussy Cancer Campus, Villejuif, France., Hollebecque A; Drug Development Department (DITEP), Gustave Roussy Cancer Campus, Villejuif, France., Nicotra C; Drug Development Department (DITEP), Gustave Roussy Cancer Campus, Villejuif, France., Ngo-Camus M; Drug Development Department (DITEP), Gustave Roussy Cancer Campus, Villejuif, France., Michiels S; Department of Biostatistics and Epidemiology, Gustave Roussy Cancer Campus, Villejuif, France., Lacroix L; INSERM U981, Gustave Roussy Cancer Campus, Villejuif, France.; Université Paris-Saclay, Paris, France.; Experimental and Translational Pathology Platform (PETRA), Genomic Platform-Molecular Biopathology Unit (BMO) and Biological Resource Center, AMMICA, INSERM US23/CNRS UMS3655, Gustave Roussy Cancer Campus, Villejuif, France.; Department of Medical Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France., Richon C; Experimental and Translational Pathology Platform (PETRA), Genomic Platform-Molecular Biopathology Unit (BMO) and Biological Resource Center, AMMICA, INSERM US23/CNRS UMS3655, Gustave Roussy Cancer Campus, Villejuif, France., Auger N; Department of Medical Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France., De Baere T; Department of Interventional Radiology, Gustave Roussy Cancer Campus, Villejuif, France., Tselikas L; Department of Interventional Radiology, Gustave Roussy Cancer Campus, Villejuif, France., Solary E; Department of Hematology, Gustave Roussy Cancer Campus, Villejuif, France., Angevin E; Drug Development Department (DITEP), Gustave Roussy Cancer Campus, Villejuif, France., Eggermont AM; Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France., Andre F; INSERM U981, Gustave Roussy Cancer Campus, Villejuif, France.; Université Paris-Saclay, Paris, France.; Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France., Massard C; INSERM U981, Gustave Roussy Cancer Campus, Villejuif, France.; Université Paris-Saclay, Paris, France.; Drug Development Department (DITEP), Gustave Roussy Cancer Campus, Villejuif, France., Olaussen KA; INSERM U981, Gustave Roussy Cancer Campus, Villejuif, France.; Université Paris-Saclay, Paris, France., Soria JC; INSERM U981, Gustave Roussy Cancer Campus, Villejuif, France.; Université Paris-Saclay, Paris, France.; Drug Development Department (DITEP), Gustave Roussy Cancer Campus, Villejuif, France., Besse B; INSERM U981, Gustave Roussy Cancer Campus, Villejuif, France.; Université Paris-Saclay, Paris, France.; Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France., Friboulet L; INSERM U981, Gustave Roussy Cancer Campus, Villejuif, France. luc.friboulet@gustaveroussy.fr.; Université Paris-Saclay, Paris, France.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Jan 01; Vol. 26 (1), pp. 242-255. Date of Electronic Publication: 2019 Oct 04.